Hemo Organic Ltd
₹ 13.7
3.47%
13 Feb
- close price
About
Incorporated in 1992, Hemo Organic Ltd is in the business of trading & distribution of Rice and Textiles.
Key Points
- Market Cap ₹ 4.76 Cr.
- Current Price ₹ 13.7
- High / Low ₹ 22.5 / 8.05
- Stock P/E 52.9
- Book Value ₹ -0.75
- Dividend Yield 0.00 %
- ROCE 2.65 %
- ROE %
- Face Value ₹ 10.0
Pros
Cons
- Promoter holding is low: 16.8%
- Company has high debtors of 382 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Services Services Commercial Services & Supplies Trading & Distributors
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.71 | 0.16 | 0.11 | 0.60 | 0.09 | 0.05 | 0.27 | 0.01 | 0.01 | 0.00 | 0.02 | 2.41 | 2.41 | |
| 0.79 | 0.22 | 0.16 | 0.68 | 0.24 | 0.17 | 0.29 | 0.06 | 0.07 | 0.05 | 0.26 | 2.45 | 2.46 | |
| Operating Profit | -0.08 | -0.06 | -0.05 | -0.08 | -0.15 | -0.12 | -0.02 | -0.05 | -0.06 | -0.05 | -0.24 | -0.04 | -0.05 |
| OPM % | -11.27% | -37.50% | -45.45% | -13.33% | -166.67% | -240.00% | -7.41% | -500.00% | -600.00% | -1,200.00% | -1.66% | -2.07% | |
| 0.23 | 0.02 | -0.71 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.07 | 0.09 | |
| Interest | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.02 | 0.00 | 0.00 |
| Depreciation | 0.09 | 0.07 | 0.06 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.04 | -0.11 | -0.82 | -0.08 | -0.15 | -0.12 | -0.02 | -0.05 | -0.06 | -0.05 | -0.26 | 0.03 | 0.04 |
| Tax % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -466.67% | |
| 0.04 | -0.11 | -0.82 | -0.08 | -0.15 | -0.12 | -0.02 | -0.05 | -0.06 | -0.05 | -0.26 | 0.16 | 0.09 | |
| EPS in Rs | 0.12 | -0.32 | -2.37 | -0.23 | -0.43 | -0.35 | -0.06 | -0.14 | -0.17 | -0.14 | -0.75 | 0.46 | 0.26 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 31% |
| 5 Years: | 55% |
| 3 Years: | 522% |
| TTM: | 11950% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 58% |
| 3 Years: | 67% |
| TTM: | 123% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | -3% |
| 5 Years: | -3% |
| 3 Years: | 13% |
| 1 Year: | 23% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | % |
Balance Sheet
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 3.40 | 3.40 | 3.40 | 3.47 | 3.47 | 3.47 | 3.47 | 3.47 | 3.47 | 3.47 | 3.47 | 3.47 | 3.47 |
| Reserves | -1.92 | -2.16 | -2.98 | -3.06 | -3.21 | -3.33 | -3.35 | -3.40 | -3.46 | -3.52 | -3.78 | -3.62 | -3.73 |
| 0.05 | 0.05 | 0.00 | 0.00 | 0.08 | 0.08 | 0.00 | 0.04 | 0.04 | 0.04 | 1.24 | 1.48 | 1.64 | |
| 0.14 | 0.08 | 0.11 | 0.72 | 0.66 | 0.73 | 0.13 | 0.12 | 0.19 | 0.35 | 0.13 | 3.65 | 3.96 | |
| Total Liabilities | 1.67 | 1.37 | 0.53 | 1.13 | 1.00 | 0.95 | 0.25 | 0.23 | 0.24 | 0.34 | 1.06 | 4.98 | 5.34 |
| 1.12 | 0.92 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 0.55 | 0.45 | 0.53 | 1.13 | 1.00 | 0.95 | 0.25 | 0.23 | 0.24 | 0.34 | 1.06 | 4.98 | 5.34 | |
| Total Assets | 1.67 | 1.37 | 0.53 | 1.13 | 1.00 | 0.95 | 0.25 | 0.23 | 0.24 | 0.34 | 1.06 | 4.98 | 5.34 |
Cash Flows
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 0.06 | 0.06 | -0.78 | -0.15 | -0.12 | -0.04 | 0.01 | -0.01 | 0.00 | 0.11 | -1.19 | -0.36 | |
| 0.02 | 0.00 | 0.70 | 0.02 | 0.06 | 0.04 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| -0.17 | 0.00 | 0.08 | 0.15 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.20 | 0.24 | |
| Net Cash Flow | -0.09 | 0.07 | 0.00 | 0.01 | -0.06 | -0.01 | 0.01 | -0.01 | 0.00 | 0.11 | 0.01 | -0.12 |
Ratios
Figures in Rs. Crores
| Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 159.37 | 342.19 | 0.00 | 438.00 | 2,920.00 | 5,402.00 | 94.63 | 2,555.00 | 2,190.00 | 1,460.00 | 381.66 | |
| Inventory Days | 0.00 | 0.00 | 0.00 | 20.66 | 91.25 | 0.00 | 0.00 | 0.00 | 730.00 | 143.18 | ||
| Days Payable | 392.55 | 3,011.25 | 4,015.00 | 366.01 | ||||||||
| Cash Conversion Cycle | 159.37 | 342.19 | 0.00 | 66.11 | 0.00 | 5,402.00 | 94.63 | 2,555.00 | -1,095.00 | 1,460.00 | 158.83 | |
| Working Capital Days | 71.97 | 114.06 | 232.27 | 146.00 | 689.44 | 438.00 | -67.59 | -1,825.00 | -4,015.00 | 11,862.50 | 156.00 | |
| ROCE % | -10.56% | -7.80% | -12.87% | -19.28% | -40.00% | -42.86% | -11.76% | -43.48% | -75.00% | -250.00% | -52.17% | 2.65% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
20h - Newspaper Advertisement of extract of Un- Audited Financial results for the quarter and nine months ended on 31.12.2025.
-
Submission Of Un-Audited Financial Results Along With Limited Review Report Thereon For The Quarter And Nine Months Ended On 31St December, 2025
1d - Submitted unaudited financial results and limited review report for quarter and nine months ended 31 Dec 2025.
-
Board Meeting Outcome for Outcome Of Board Meeting Held Today I.E., Friday, 13Th February, 2026
1d - Approved unaudited standalone financial results for quarter and nine months ended Dec 31, 2025; limited review.
-
Board Meeting Intimation for Board Meeting Intimation For Meeting To Be Held On Friday, 13Th February, 2026.
10 Feb - Board meeting on 13 Feb 2026 to consider unaudited Q3 and nine-month financial results and limited review report.
- Submission Of Voting Result Of Extra Ordinary General Meeting Of M/S. Hemo Organics Limited 9 Jan
Annual reports
-
Financial Year 2025
from bse
-
Financial Year 2024
from bse
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
Business Overview:[1]
HOL is engaged in agro trading across domestic and international markets. Its activities include buying, selling, reselling, importing, exporting, transporting, storing, developing, promoting, marketing, and supplying goods. The company operates at both retail and wholesale levels.